Brief: CSL Limited Reports 13.5% Stake In Cara Therapeutics
30/10/2024 22:26
Oct 30 (Reuters) -
CSL Limited:
* CSL LIMITED REPORTS 13.5% STAKE IN CARA THERAPEUTICS INC
AS OF
OCT 23 - SEC FILING
Source text: ID:n0001193125-24-247585
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tvardi Therapeutics
See all newsTvardi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tvardi Therapeutics Q2 net loss slightly lower estimates
Brief: Tvardi Therapeutics Inc Q2 Net Income USD -6.5 Million Vs. IBES Estimate USD -6.54 Million
Tvardi Therapeutics, Inc. expected to post a loss of 70 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:50 PM